BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

564 related articles for article (PubMed ID: 17979841)

  • 1. From cancer immunosurveillance to cancer immunotherapy.
    Stagg J; Johnstone RW; Smyth MJ
    Immunol Rev; 2007 Dec; 220():82-101. PubMed ID: 17979841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell intrinsic mechanisms of T-cell inhibition and application to cancer therapy.
    Peggs KS; Quezada SA; Allison JP
    Immunol Rev; 2008 Aug; 224():141-65. PubMed ID: 18759925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immune response and cancer].
    El Hage F; Abouzahr-Rifai S; Meslin F; Mami-Chouaib F; Chouaib S
    Bull Cancer; 2008 Jan; 95(1):57-67. PubMed ID: 18230571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A fresh look at tumor immunosurveillance and immunotherapy.
    Smyth MJ; Godfrey DI; Trapani JA
    Nat Immunol; 2001 Apr; 2(4):293-9. PubMed ID: 11276199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting costimulatory pathways for tumor immunotherapy.
    Ward RC; Kaufman HL
    Int Rev Immunol; 2007; 26(3-4):161-96. PubMed ID: 17558743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improving cancer immunotherapy by targeting tumor-induced immune suppression.
    Stewart TJ; Smyth MJ
    Cancer Metastasis Rev; 2011 Mar; 30(1):125-40. PubMed ID: 21249424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monitoring cellular immune responses to cancer immunotherapy.
    Morse MA; Clay TM; Hobeika AC; Mosca PJ; Lyerly HK
    Curr Opin Mol Ther; 2001 Feb; 3(1):45-52. PubMed ID: 11249731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The promise of 4-1BB (CD137)-mediated immunomodulation and the immunotherapy of cancer.
    Lynch DH
    Immunol Rev; 2008 Apr; 222():277-86. PubMed ID: 18364008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunogenic anti-cancer chemotherapy as an emerging concept.
    Haynes NM; van der Most RG; Lake RA; Smyth MJ
    Curr Opin Immunol; 2008 Oct; 20(5):545-57. PubMed ID: 18573339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imaging the immune response to monitor tumor immunotherapy.
    Wang Q; Ornstein M; Kaufman HL
    Expert Rev Vaccines; 2009 Oct; 8(10):1427-37. PubMed ID: 19803763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of T-cell inhibition: implications for cancer immunotherapy.
    Mittendorf EA; Sharma P
    Expert Rev Vaccines; 2010 Jan; 9(1):89-105. PubMed ID: 20021308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strategies to enhance the therapeutic activity of cancer vaccines: using melanoma as a model.
    Berinstein NL
    Ann N Y Acad Sci; 2009 Sep; 1174():107-17. PubMed ID: 19769743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emerging strategies in regulatory T-cell immunotherapies.
    Gajewski TF; Chesney J; Curriel TJ
    Clin Adv Hematol Oncol; 2009 Jan; 7(1):1-10; quiz 11-2. PubMed ID: 19288606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted therapies to improve tumor immunotherapy.
    Begley J; Ribas A
    Clin Cancer Res; 2008 Jul; 14(14):4385-91. PubMed ID: 18628452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Boosting the immune response: an alternative combination therapy for cancer patients.
    Thyphronitis G; Koutsilieris M
    Anticancer Res; 2004; 24(4):2443-53. PubMed ID: 15330197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutics targeting tumor immune escape: towards the development of new generation anticancer vaccines.
    Mocellin S; Nitti D
    Med Res Rev; 2008 May; 28(3):413-44. PubMed ID: 17694549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NK cell-based cancer immunotherapy.
    Stagg J; Smyth MJ
    Drug News Perspect; 2007 Apr; 20(3):155-63. PubMed ID: 17520092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer despite immunosurveillance: immunoselection and immunosubversion.
    Zitvogel L; Tesniere A; Kroemer G
    Nat Rev Immunol; 2006 Oct; 6(10):715-27. PubMed ID: 16977338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of gene transfer in cancer immunotherapy.
    Dranoff G
    Forum (Genova); 1998; 8(4):357-64. PubMed ID: 9863030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The immune system--is it relevant to cancer development, progression and treatment?
    Prestwich RJ; Errington F; Hatfield P; Merrick AE; Ilett EJ; Selby PJ; Melcher AA
    Clin Oncol (R Coll Radiol); 2008 Mar; 20(2):101-12. PubMed ID: 18037277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.